2Boyd AH, Eastwood NB, Parker C JR, et al.Pharmacodynamics of the 1R cis-l"R cis isomer of atracurium(51W89) in health and renal failure.Br J Anaesth, 1995,74 (4) : 400-404.
10Della RG,Pompei L,Coccia C,et al.Atracurium, cisatracuium, vecuronium and rocuronium in patients with renal failure.Minerva Anestesiol, 2003,69 (7-8) : 605-615.
二级参考文献41
1郑武飞.实用临床免疫学技术[M].北京:人民卫生出版社,1987.186.
2Barake A. Test dose for prediction of mivacurium sensitivity in the patient with atypical plasma cholinesterase[J].Anesthessiology , 1995,83 : 1371-1372.
3Lien CA, Belmont MR, Abalos A, et al. The cardiovascular elects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia [J ]. Anesthesiology ,1995,82(5) : 1131-1138.
4Melloni C. Cisatracurium versuset alvecuronium: a comparative , double blind , randomized , multieenter study in adult patients under propofol/fentanyl/ N2O anesthesia [J].Minerva Anestesiol , 2007 , 72 (5) : 299-308.
5Taivainen T, Meakin GH , Meretoja OA, et al . The safety and efficacy of eisatracurium 0.15 mg/kg during nitrous oxide opioid anaesthesia in infants and children [J]. Anaesthesia , 2000 ,55 : 10472-1051.
6Belment MR. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide /opioid/babiturate anesthesia[J]. Ansthesiology , 1995,82 : 1139-1145.
7Rosow CE, Basta SJ, Savarese JJ, et al. Correlation of cardiovascular effects with increases in plasma histamineC J]. Anesthesiology,1980, 53 : S270.
8Verburg KM, Bowsher RR, Henry DP. A new radioenzymatic assay for histamine using purified histamine N-methyltransferase [ J ]. Life Scienses, 1983, 32:2855 -2867.
9Moss J. Muscle relaxants and histamine release[ J]. Acta Anaesthesiol Scand, 1995, 106 (Suppl) : 7 - 12.
10Belmont MR, Lien CA, Quassy S, et aL The clinic neuromuscular pharmacology of 51 W89 in patients receiving nitrous oxide/opioid/barbiturate anaesthesia [ J ]. Anesthesiology, 1995, 82:1139 -1145.
